Cogentin

Active Ingredient(s): Benztropine
FDA Approved: * March 5, 1954
Pharm Company: * MERCK
Category: Parkinsons

Benzatropine (INN[1]), known as benztropine in the United States and Japan,[2] is a medication used to treat a type of movement disorder due to antipsychotics known as dystonia and parkinsonism.[3] It is not useful for tardive dyskinesia.[3] It is taken by mouth or by injection into a vein or muscle.[3] Benefits are seen within two hours and last for up to ten hours.[4][5] Common si... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
7 Discussions